Bother with dripping or leaking at baseline and following SBRT for prostate cancer- Question 4 of the EPIC-26. (a) Patients were stratified to three groups: no problem, very small-small problem and moderate-big problem. The percentage of patients in each group at each time point is depicted in the bar chart. (b) Average EPIC bother with dripping or leaking scores at baseline and following SBRT for prostate cancer. Thresholds for clinically significant changes in scores (½ standard deviation above and below the baseline) are marked with dashed lines. EPIC scores range from 0–100 with higher values representing a more favorable health-related QOL.